Prediction of Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
基本信息
- 批准号:8731999
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAgeAlgorithmsAntibodiesAntibody Binding SitesAntibody RepertoireAntigen TargetingAntigen-Antibody ComplexAntigensAutoimmune DiseasesBenchmarkingBindingBiologicalBiological ModelsBiological PhenomenaBone MarrowChargeComplement component C1sComplementarity Determining RegionsComplexDataDiseaseDockingElectrostaticsEnzymesEpitopesFood HypersensitivityFreedomGenomicsGoalsGraft RejectionHigh-Throughput Nucleotide SequencingHomology ModelingHumanImmune systemImmunologyIndividualInflammatoryInternetKnowledgeLightMapsMedicalMethodsModelingMolecular ConformationMovementMusMutationOvalbuminPatientsPharmaceutical PreparationsPlasma CellsPlayPoint MutationPositioning AttributeProtein BindingProteinsResearchResolutionResourcesRoleSamplingSideSpecificityStructural ModelsStructureSystemTestingTherapeuticTherapeutic antibodiesTimeTransplantationUncertaintyVaccinesVertebral columnWorkantigen antibody bindingcomplement systemdensitydesignflexibilityfood allergenimprovedinsightkinematicsmolecular recognitionnovelpolyclonal antibodyprotein structure predictionresearch studystatisticstherapeutic developmenttherapeutic targetthree dimensional structurevaccine development
项目摘要
DESCRIPTION (provided by applicant): Antibodies play a critical role in the immune system for recognition of foreign intruders. Because of their excellent affinity and specificity, they hav also been exploited as therapeutic molecules and biotechnological components for sensing and assembly. Structures of antibodies in complex with their antigens can yield insight into biological
phenomena or drug and disease mechanisms. However, structures of antibodies and antibody-antigen complexes can be difficult, time consuming, and expensive to determine. The proposed research focuses on the computational prediction of the structure of antibodies and antibody-antigen complexes. Computational approaches are particularly important because the repertoire of antibodies in a human patient is far too large for complete structural characterization by experiment. Prior work has isolated the most critical challenges: most of the antibodies in the human repertoire have hypervariable CDR H3 loops longer than that which is predictable using current loop methods; backbone conformational uncertainty and flexibility confound current docking methods; and no current method can quantitatively predict antibody-antigen binding affinities from structure. Thus, the first three aims of the project are to (1) develop new methods
to predict the structure of long CDR H3 loops using statistics to identify likely ¿ turns, (2) develop flexible backbone docking routines using an expanded ensemble approach with a conformational web, and (3) develop methods to quantitatively predict protein-protein binding affinity using improved electrostatics treatments. Finally, the fourth aim will be to (4) use existng and proposed methods to predict structures of antibodies and antibody-antigen complexes for entire polyclonal antibody repertoires. Structures will be predicted for antibody repertoires determined from bone marrow plasma cells of mice immunized against ovalbumin (a food allergen) and enzyme C1s (a therapeutic target for autoimmune diseases and transplant tolerance). Ultimately, these studies will yield insights into immunology, molecular recognition, and design of protein-protein interfaces and vaccines.
描述(应用程序提供):抗体在识别外国入侵者的免疫系统中起关键作用。由于它们具有出色的亲和力和特异性,因此也被探讨为具有敏感性和组装的治疗分子和生物技术成分。与其抗原复杂的抗体结构可以洞悉生物学
现象或药物和疾病机制。但是,抗体和抗体 - 抗原络合物的结构可能很困难,耗时且昂贵。拟议的研究重点是抗体和抗体 - 抗原复合物结构的计算预测。计算方法尤其重要,因为人类患者中抗体的曲目太大了,无法通过实验进行完整的结构表征。先前的工作隔离了最关键的挑战:人类曲目中的大多数抗体的CDR H3环比使用当前环路方法可预测的抗体更长。骨干构象不确定性和灵活性混淆了当前的对接方法;并且当前的方法无法定量预测结构的抗体 - 抗原结合亲和力。这是该项目的前三个目标是(1)开发新方法
为了使用统计数据来预测长CDR H3回路的结构,以识别可能的转弯,(2)使用构型Web的扩展集合方法开发灵活的骨干对接例程,并且(3)开发方法以使用改进的静电处理来定量预测蛋白质 - 蛋白质结合亲和力。最后,第四个目标是(4)使用现有的和提出的方法来预测整个多克隆抗体库的抗体和抗体 - 抗原复合物的结构。将预测由针对卵蛋白(食物过敏原)和酶C1(自身免疫性疾病和移植耐受性的治疗靶标)免疫的小鼠的骨髓浆细胞确定的抗体。最终,这些研究将产生对免疫学,分子识别以及蛋白质蛋白界面和疫苗设计的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY J GRAY其他文献
JEFFREY J GRAY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY J GRAY', 18)}}的其他基金
Prediction of the Structures of Protein Complexes
蛋白质复合物结构的预测
- 批准号:
10206954 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Prediction of the Structures of Protein Complexes
蛋白质复合物结构的预测
- 批准号:
10407529 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Prediction of the Structures of Protein Complexes
蛋白质复合物结构的预测
- 批准号:
10693822 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Glycomutagenesis Tools for Structure-Based Prediction and Design of Glycosyl Transfer
用于基于结构的糖基转移预测和设计的糖突变工具
- 批准号:
9897664 - 财政年份:2018
- 资助金额:
$ 2.11万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
7487309 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
8546392 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
7680247 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体及其抗原结构的预测
- 批准号:
9923648 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
7132766 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
7279806 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
- 批准号:
10726508 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:
10597840 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Fibroblasts in the establishment of the liver pre-metastatic niche
成纤维细胞在肝脏转移前生态位的建立中
- 批准号:
10742193 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别: